🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as gemcitabine hydrochloride, c...
Status
Completed
Location
Sussex Cancer Centre at Royal Sussex County Hospital
Start Date
2006-03
Trial ID
NCT00971763
Treatments Being Tested
This phase 3b study will compare the immunogenicity and reactogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871000
Treatments Being Tested
This multicenter, open-label, dose-escalation study will evaluate the safet...
Status
Completed
Location
The University of Alabama at Birmingham
Start Date
2013-11-29
Trial ID
NCT01992653
Treatments Being Tested
Esophageal cancer is the sixth most common cause of cancer deaths worldwide...
Status
Unknown
Location
Severance Hospital
Start Date
2019-04-01
Trial ID
NCT03770988
Treatments Being Tested
The goal of this study is to evaluate the efficacy and safety of a combinat...
Status
Unknown
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2024-02-29
Trial ID
NCT06434662
Treatments Being Tested
Assess the safety and immunogenicity of a 3-dose schedule (at 2, 4, 6 month...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-11
Trial ID
NCT02173704
Treatments Being Tested
To evaluate the safety and immunogenicity of GSK Biologicals' live attenuat...
Status
Completed
Location
Multiple Locations
Start Date
2000-11
Trial ID
NCT00388440
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-10-06
Trial ID
NCT00197015
This study will evaluate the safety, efficacy, and pharmacokinetics of indu...
Status
Completed
Location
Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital
Start Date
2016-03-24
Trial ID
NCT02600897
Treatments Being Tested